Advertisement
Advertisement

MGNX

MGNX logo

MacroGenics, Inc.

4.54
USD
Sponsored
+0.22
+5.09%
Jul 21, 16:00 UTC -4
Closed
exchange

After-Market

4.57

+0.03
+0.57%

MGNX Earnings Reports

Positive Surprise Ratio

MGNX beat 19 of 42 last estimates.

45%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$68.80M
/
-$0.01
Implied change from Q1 26 (Revenue/ EPS)
+231.19%
/
-98.25%
Implied change from Q2 25 (Revenue/ EPS)
+209.36%
/
-98.21%

MacroGenics, Inc. earnings per share and revenue

On May 13, 2026, MGNX reported earnings of -0.57 USD per share (EPS) for Q1 26, beating the estimate of -0.58 USD, resulting in a 0.45% surprise. Revenue reached 20.77 million, compared to an expected 15.35 million, with a 35.33% difference. The market reacted with a +20.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 68.80 million USD, implying an decrease of -98.25% EPS, and increase of 231.19% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Jul 14, 2026 For Q4 26
Estimate
-
Actual
-$0.67
Surprise
-
logo
Abbott Laboratories
Report Date
Jul 16, 2026 For Q2 26
Estimate
$1.29
Actual
$1.31
Surprise
+1.38%
FAQ
For Q1 2026, MacroGenics, Inc. reported EPS of -$0.57, missing estimates by 0.45%, and revenue of $20.77M, 35.33% above expectations.
The stock price moved up 20.58%, changed from $3.45 before the earnings release to $4.16 the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on 6 analysts, MacroGenics, Inc. is expected to report EPS of -$0.01 and revenue of $68.80M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement